SweetValueLab
Write for us

Hillman Capital

Hillman Capital Management, Inc.CIK 0001314620Form 13F-HR on EDGAR
Portfolio value$138.2M
Positions54
QuarterQ2 2026ended 2026-06-30
Filed08/142026

Hillman Capital Management, Inc.'s Q2 2026 13F, filed Aug 14, 2026, reports 54 positions worth $138.2M. The ten largest are 36.3% of the book, led by CVS Health at 4.2%, Biogen at 3.8% and DuPont at 3.7%. Against Q1 2026: 3 bought, 14 added to, 35 reduced, 5 sold; the largest moves were sold DuPont and bought DuPont.

Where the money is

top 10 = 36% of the portfolio

Holdings

54 positions · Q2 2026 · change vs Q1 2026
TickerIssuerWeightValueQ-end → nowPrice vs modelChange

Source: the manager's Form 13F-HR on SEC EDGAR, kept as immutable quarterly snapshots; changes compare two consecutive filings. A 13F is filed up to 45 days after quarter end and covers US-listed long positions only. Tickers come from a self-maintained CUSIP map; a position without one shows its CUSIP. Method notes in where the numbers come from.